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Abstract – To overcome nutritional vitamin B12 deﬁciencies in certain populations in Southern
Africa, fortiﬁed functional foods have been developed. However, current microbiological methods
used to accurately determine vitamin B12 levels in foodstuffs, important for quality control and
regulatory purposes, are time consuming. This study describes an extraction and detection method
for vitamin B12 in dairy products and growth media cultured with Propionibacterium freudenrei-
chii. Samples were extracted by mixing in KCN buffer (pH 4.5), autoclaving at 121 °C for 25 min,
cooling and centrifugation. The resultant supernatant was syringe-ﬁltered prior to reversed-phase
HPLC analysis using a methanol-water gradient that was effective in resolving the B12 peak. The
method offered excellent linearity with a regression coefﬁcient R > 0.998. The limit of
quantiﬁcation was 0.005 μg·mL−1 sample. For samples with vitamin B12 concentrations well
within the linear range of the assay, good repeatability was demonstrated for the same sample with
mean concentrations of 2.62 ± 0.02 and 2.61 ± 0.02 μg·mL−1 detected on day 1 and day 2,
respectively. Recovery values ranged from 98.6% to 103.2%, indicating that the extraction method
ensured complete dissolution of vitamin B12 from the matrices under study. Sensitivity was
enhanced by sample concentration and puriﬁcation using a series of solid phase extraction steps
which resulted in improved peak resolution and removal of interfering peaks. The method was
validated by comparison of the HPLC results of the same sample with those obtained using
traditional microbiological methods. The method is a rapid alternative to the more time-consuming
microbiological assay.
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摘要 – HPLC 法快速提取和定量测定乳制品和费氏丙酸杆菌发酵产品中维生素 B12○ 为了
治疗南非部分人群中出现的维生素 B12 缺乏症，在一些功能性食品中强化了维生素 B12○
然而目前用于食品中维生素 B12 检测的方法是微生物发酵法，该法特点是耗时○ 本文研究了
乳制品和费氏丙酸杆菌 (Propionibacterium freudenreichii) 发酵产品中维生素 B12 的提取和测
定方法○ 乳样品与 KCN (pH 4.5)缓冲溶液混合，在 121 °C下高压灭菌 25 min，冷却、离心○
上清液用于 RP-HPLC 分析，甲醇-水为流动相，进行梯度洗脱○ 方法的线性回归系数为
R > 0.998○ 定量检测限位为 0.005 μg·mL−1○ 样品中维生素 B12 的浓度在测定方法的线性
范围之内，方法的重现性较好，同一样品在第一天和第二天的测定值分别为 2.62 ± 0.02 μg·mL−1
和 2.61 ± 0.02 μg·mL−1○ 方法的回收率在 98.6%  103.2%，表明所采用的提取方法能够完全溶
*Corresponding author (通讯作者): vanwykj@cput.ac.za
Dairy Sci. Technol. 90 (2010) 509–520





扰峰，维生素 B12 的色谱峰形好，使分析方法的灵敏度大大提高○ 将本研究方法的实验
结果与传统微生物法测定的结果进行了对比，证明该法是快速、准确、可行的维生素 B12
分析方法○
Propionibacterium freudenreichii / 微生物测定法 / HPLC / 维生素 B12
Résumé – Une méthode HPLC rapide pour extraire et quantiﬁer la vitamine B12 dans les
produits laitiers et les cultures de Propionibacterium freudenreichii. Pour lutter contre les ca-
rences en vitamine B12 parmi certaines populations d’Afrique du Sud, des aliments fonctionnels
enrichis ont été développés. Cependant, les méthodes actuelles utilisées pour analyser précisément
le niveau de vitamine B12 dans les aliments, qui sont importantes à des ﬁns de contrôle-qualité et de
législation, sont coûteuses en temps. Cet article décrit une méthode d’extraction et de détection de
la vitamine B12 dans les produits laitiers et les cultures de Propionibacterium freudenreichii. Les
échantillons étaient extraits par mélange à du tampon KCN, pH 4,5 et autoclavage à 121 °C pendant
25 min, refroidissement et centrifugation. Le surnageant résultant était ﬁltré puis analysé par HPLC
en phase inverse en utilisant un gradient méthanol-eau, qui permettait une bonne résolution du pic
de vitamine B12. La méthode montrait une bonne linéarité, avec un coefﬁcient de régression
R > 0,998. La limite de quantiﬁcation était de 0,005 μg·mL−1 d’échantillon. Pour des échantillons
contenant des concentrations dans la moyenne de la gamme de linéarité, la répétabilité a été établie,
avec des valeurs obtenues pour le même échantillon à deux jours différents de 2,62 ± 0,02 μg·mL−1
et 2,61 ± 0,02 μg·mL−1. Les rendements d’extraction variaient entre 98,6–103,2 %, ce qui indique
que la méthode d’extraction permettait une dissolution complète de la vitamine B12 des matrices
étudiées. La méthode HPLC était validée en comparant les résultats obtenus avec ceux de la
méthode microbiologique de référence. La sensibilité de la méthode était améliorée par une série
d’étapes d’extraction en phase solide pour concentrer et puriﬁer les échantillons, ce qui améliorait la
résolution des pics et éliminait les pics contaminants. La méthode décrite est une alternative rapide
à la méthode microbiologique de référence.
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1. INTRODUCTION
Vitamin B12 plays many important roles
in normal metabolism [6]. Subnormal vita-
min B12 levels have been linked to revers-
ible dementia [30], while vitamin B12
deﬁciency results in pernicious anaemia
and is also manifested by neurological
changes which could culminate in brain
damage [6, 16]. Deﬁciency had also been
associated with cerebellar ataxia [26], trig-
gering seizures in epileptics [29] and revers-
ible involuntary movements in adults [8].
More recently, low folate and vitamin B12
levels have been linked to psychiatric dis-
eases, such as bipolar disorder [28]. Further-
more, not only were low vitamin B12 levels
recorded in HIV-infected patients [14], but
cobalamins demonstrated anti-retroviral
activity against HIV-1 in vitro [23, 32],
and the possibility that adequate vitamin B12
may slow the onset of AIDS in HIV-posi-
tive individuals was also reported [2].
Since chemical synthesis is extremely
complex, only biosynthetic processes are
used for the commercial production of vita-
min B12 [27]. The microorganisms most
widely used in these fermentations
include Propionibacterium spp. [13, 27],
Pseudomonas denitriﬁcans [21], methano-
gens (Methanosarcina barkeri, Methano-
bacterium spp.) and Bacillus spp. [24, 34].
However, since some Propionibacterium
species were granted GRAS (generally
recognised as safe) status by the United
States Food and Drug Administration [27],
as well as European QPS (qualiﬁed pre-
sumption of safety) status [4], they are the
preferred organisms for vitamin B12 produc-
tion [27]. Although Propionibacterium
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freudenreichii retains most of the synthes-
ised vitamin intracellularly [35], the vitamin
is readily released in acidic solutions (pH <
5.0), including the human stomach, thus
ensuring bioavailability when ingested [31].
Since vitamin B12 deﬁciencies are preva-
lent among the poor in Southern Africa
[10, 18], there is a need to produce fortiﬁed
functional foods tocombat thesedeﬁciencies.
However, since activity may be lost during
processing and storage, quantiﬁcation of
vitamin B12 is needed to ensure quality con-
trol, to satisfygovernment regulatory require-
ments, including nutrition labelling [3, 12].
Vitamin B12 assay techniques include
microbiological assays, radioisotope dilu-
tion assay, electrothermal atomic absorption
spectrometry, capillary electrophoresis,
chemiluminescence techniques, biomolecu-
lar interaction analysis (BIA) and a combi-
nation of ﬂuorescence resonance energy
transfer (FRET) and ﬂow-injection analysis
(FIA) [1, 6, 12, 22, 33]. The microbiological
assay is still the ofﬁcial method, but is very
laborious [1]. High-performance liquid
chromatography (HPLC) has been
employed by a number of workers to assay
vitamin B12 in multivitamin and mineral
tablets. These matrices are less complex
than foodstuffs and, therefore, extraction
and resolution of the vitamin is simple in
comparison [20, 22, 25]. More recently,
reversed-phase HPLC methods with immu-
noafﬁnity extraction and UV detection [15],
and coulometric electrochemical detection
[19] were used to assay vitamin B12 in pet-
food and various infant formulae [15] and
fortiﬁed fruit juice and various seafoods
[19]. However, these food matrices did not
include complex dairy products. Further-
more, none of the above-mentioned stud-
ies included extraction and analysis of
vitamin B12 from propionibacteria (PAB).
Hence, the aim of this study was to develop
and optimise both an extraction protocol
and an HPLC method that will afford a
more rapid vitamin B12 analysis of milk
and fermented dairy products, as well as
of synthetic media cultured with P. freud-
enreichii strains.
2. MATERIALS AND METHODS
2.1. Chemicals, reagents
and other materials
Vitamin B12 (cyanocobalamin) (Fluka)
standardwas used.Methanol (BDS) and ace-
tonitrile (BDS) were of HPLC grade. All
other chemicals were of Analar grade.
Reverse osmosis Milli-Q water (18 MΩ),
puriﬁed with a Milli-Q water puriﬁcation
system (Millipore, Microsep, Bellville,
South Africa), was used for all solutions
and dilutions.
The KCN-acetate buffer consisted of
(g·L−1) 20 g KCN (Saarchem) and 544.32 g
sodium acetate (CH3COONa) (Saarchem).
Prior to dilution to the required concentration,
the pHwas adjusted to 4.5 using glacial acetic
acid (BDH Chemicals) [19]. The medium
(B12 medium) used to enhance vitamin B12
synthesis consisted of (g·L−1): polypeptone
(BBL) 12.5; casamino acids (Difco) 11.0;
yeast extract (Difco) 2.5; NaH2PO4·2H2O
(Merck) 2.25; MgCl2·6H2O (Merck) 0.4;
K3P04 (Merck) 1.76; CoCl2·6H2O (Merck)
0.018; FeSO4·7H2O (Merck) 0.01; D-cal-
cium-pantothenate (Fluka) 0.004; (+)-Biotin
(Fluka) 0.0003; Tween 80 (Saarchem)
1.0 mL; glucose (BDH Chemicals) 40; and
5,6-dimethylbenzimidazole (DBI) (Merck)
0.07. The pH of the medium was adjusted
to 7.0 with 40 g·L−1 NaOH prior to autoclav-
ing at 121 °C for 15 min [35]. Yeast extract
sodium lactate (YEL) broth contained in
g·L−1: yeast extract (Oxoid) 5.0; sodium
lactate syrup (500 g·L−1) (Saarchem) 20.0;
peptone (Biolab) 2.0; KH2PO4 (Merck)
10.0; and Tween 80 (Saarchem) 1.0 mL [7].
Eight strains of P. freudenreichii were
used. Strains J8, J9, J10, J15 and J16 were
obtained from the culture collection of the
Department of Food Science, University of
Stellenbosch, strain J17 (ATCC 13673) from
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the American Type Culture Collection and
strains J18 and J19 from the All Russian
Collection of Microorganisms, Pushino
IBFM, Russian Academy of Sciences. The
inoculum volume was 200 μL·100 mL−1
broth, with a cell count of 1 × 107 cfu·mL−1
(variation of 5% at ﬁnal count). The test
organism used in the microbiological assay,
Lactobacillus delbrueckii ssp. lactis (ATCC
7830), was obtained from the South African
Bureau of Standards (SABS).
UHT skim milk, 10 g·L−1 fat content,
UHT full cream milk, 33 g·L−1 fat content
and “Amasi”, 50 g·L−1 fat content, a fer-
mented milk product generally consumed
in Southern Africa, were purchased from
a local supermarket. Keﬁr grains were
obtained from the Department of Food
Science, University of Stellenbosch. Reacti-
vation of the Keﬁr grains was achieved by
adding 30 mL milk to 10 g grains and
incubating at 25 °C for 12 h, with agita-
tion. The milk phase was drained using a
sterilised metal strainer. The grains were
then inoculated into 100 mL UHT full
cream milk and incubated at 25 °C for
12 h, after which the grains were separated
from the Keﬁr beverage. Reactivated grains
were also co-inoculated with strain J15 to
obtain Keﬁr beverage samples fortiﬁed
with vitamin B12.
2.2. Standard solutions
The stock solution was prepared
bimonthly by weighing out 4.0 mg cyanoco-
balamin and diluting it to 200 mL with
KCN-acetate buffer in amber glassware and
covering the container with aluminium foil.
This solution, stored at 4 °C, was used to
make dilutions as required for both theHPLC
and microbiological assays and was com-
pletely stable for a minimum of ﬁve months.
Since cobalamin powders are very hygro-
scopic [6] and sensitive to light [17], prior
to preparing a fresh stock solution, the pow-
der was dried to constantmass in a desiccator




The inherent sensitivity of the HPLC
method was determined by analysing a ser-
ies of vitamin B12 standard solutions,
increasing linearly in concentration from
0.005 to 15 μg·mL−1 sample. The range
of concentrations was chosen based on
vitamin B12 levels (in μg·mL
−1 sample)
reported for dairy products (0.003–0.012
[11]) and synthesised by PAB (0.02 [5];
0.14 [9]; and 12.50 [35]).
Seven samples per concentration were
analysed (n = 7) and the resultant computed
vitamin B12 concentration was plotted
against the actual (i.e. expected) vitamin B12
concentration. A linear regression line, cal-
culated by the method of least squares,
was indicated. In addition, the correlation
coefﬁcient (R2) and the regression coefﬁ-
cient (R) were calculated.
2.3.2. Repeatability
An homogeneous sample was divided
into 14 aliquots, and the vitamin B12 con-
centration was determined in two series of
seven aliquots on two successive days.
2.3.3. Recovery
A sample or placebo, i.e. a sample that
initially contained no cyanocobalamin, was
spiked with a known quantity of cyanoco-
balamin. After the normal extraction proce-
dure, the added amount of cyanocobalamin
was measured to determine the percentage
recovery.
2.3.4. Validity
Using a selection of samples, the validity
of the HPLC results was established
by performing the microbiological assay
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on aliquots of the same extract. All assays
were performed in triplicate.
2.4. Sample extraction
The ratio of KCN-acetate extraction buf-
fer (pH 4.5) to broth sample was 10:4 (v/v).
The samples were protected from light as
described. Autoclaving at 121 °C for
25 min was followed by rapid cooling and
centrifugation at 15 000× g for 10 min at
4 °C. This was followed by (1) ﬁltration
through a 0.22-μm syringe ﬁlter (Cameo,
Osmonics, Sigma Aldrich) into amber sam-
ple vials with solid caps (HPLC method)
and (2) suitable dilutions, followed by inoc-
ulation (microbiological assay). HPLC sam-
ples that were not analysed immediately
were stored at 4 °C in the dark.
The presence of cyanide in the extrac-
tion buffer is critically important to ensure
quantitative conversion of all forms of
vitamin B12 to cyanocobalamin, the most
stable form of the vitamin, while the heat
treatment liberates all protein-bound cobala-
min [6]. Hence, this extraction method was




Since the vitamin B12 content of some
dairy products is as low as 0.003 μg·mL−1
[11], sample puriﬁcation and concentration
was investigated to improve the sensitivity
of the analysis. Solid phase extraction
(SPE) columns were used to both purify
and concentrate the sample. Puriﬁca-
tion involved application of 9–12 mL
sample extract to a preconditioned SPE
column (Chromabond SB/3 mL/500 mg,
Macherey-Nagel, Düren, Germany) and col-
lecting the eluate, i.e. the puriﬁed sample
extract, for HPLC analysis. When sample
concentration followed puriﬁcation, immedi-
ately after collecting the puriﬁed sample
extract, any vitamin B12 remaining on the
SPEcolumnwaselutedwith one columnvol-
ume 400 mL·L−1 methanol (HPLC grade,
BDS). This second eluate was collected sep-
arately. A preconditioned Chromabond
C18ec/6 mL/1000 mg column (Macherey-
Nagel) was then used to concentrate the sam-
ple. To achieve this, the ﬁrst eluate (i.e. the
puriﬁed sample extract) was applied to the
column. The vitamin B12, which remains as
a visible pink to red band on the column,
was then eluted using the second eluate (col-
lectedseparatelyduring thepuriﬁcationstep),
followed by 1 mL 900 mL·L−1 methanol.
After ﬂash evaporation of the methanol in a
rotary evaporator at 40 °C, the concentrate
was diluted with Milli-Q water to 3 mL in
a volumetric ﬂask. Syringe ﬁltration
(0.22-μmCameo,Osmonics, SigmaAldrich)
into amber glass vials preceded the HPLC
analyses.
2.6. HPLC
The HPLC separations were performed
using a Hewlett-Packard 1100 HPLC sys-
tem, equipped with a vacuum degassing
unit, a quaternary pump and a Rheodyne
7125 injection valve ﬁtted with a 20-μL
sample loop. A 50-μL syringe was
employed to ensure improved accuracy with
respect to delivery of the desired 20-μL
sample volume. A variable wavelength
detector set at 361 nm was used. The HP
Chemstation software (Hewlett-Packard,
Waldbron, Germany) integrated, recorded
and calculated the peak areas and was used
to store data.
A range of chromatographic conditions
was employed in an attempt to optimise peak
resolution and response (peak area). These
included the use of different analytical col-
umns, adjusting the ﬂow rate and increasing
and decreasing the slope of the solvent gradi-
ent. Optimum conditions were found when
the analytical column used was a 5-μm
BDS-C18 column (250 × 2 mm internal
diameter, i.d.) produced by Hewlett-
Packard (Waldbron, Germany). A guard
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cartridge (ThermoQuest, Needham,
Massachusetts) (4 × 4 mm i.d.) packed with
5 μm Hypersil BDS-C18 packing material
was installed ahead of the analytical column.
The guard cartridge was consistently
replaced after 150–200 injections. The
mobile phase was a 15:85 to 50:50 (v/v)
methanol-water linear gradient over 25 min
with a ﬂow rate of 0.35 mL·min−1. The
retention time of cyanocobalamin was
12.46 ± 0.48 min under these conditions.
Utilising the calibration function of the
HP Chemstation software to construe the
calibration curve, quantiﬁcation of the vita-
min B12 levels of samples was performed
by the external standard method. Hence, a
standard solution diluted to a known con-
centration on the day was analysed in dupli-
cate and the software programmed to use
the resultant peak area to calculate the con-
centration of vitamin B12 in the samples.
Regeneration of the column between injec-
tions entailed post-run ﬂushing with 100%
acetonitrile (5 min), followed by 100%
water (5 min), and then recycled to initial
conditions (5 min).
2.7. Microbiological assay
The microbiological assay method
of Angyal [1], with modiﬁcations, was
employed. The test organism, L. delbrueckii
ssp. lactis ATCC 7830, was routinely cul-
tured in MRS broth or MRS agar (Biolab).
One day prior to the assay, the culture was
inoculated into Bacto Lactobacilli broth
AOAC (Difco) liquid culture medium and
incubated at 37 °C. On the day of the assay,
the cultures were centrifuged (10 000× g,
10 min, 4 °C), the cells were washed and
resuspended in a 10 mL sterile physiological
saline solution (p.s.s.) under aseptic condi-
tions. To obtain the inoculum, this cell sus-
pension was diluted with sterile p.s.s. to
60 %T (read against sterile saline set at
100 %T).
The requisite standard solutions (with
cyanocobalamin concentrations of 0.01,
0.014 and 0.02 ng·mL−1) were prepared
by diluting the stock solution with the
KCN-acetate buffer and not with 25% alco-
hol as suggested by Angyal [1].
As mentioned earlier, since the KCN buf-
fer ensures superior vitamin B12 stability in
the sample extract [6], it was preferred
to the metabisulphite buffer described
by Angyal [1]. Furthermore, since replicate
samples were assayed using the HPLC, the
extraction procedurewas as described earlier.
After preparation and sterilisation of the
standard and assay tubes, a Distriman repea-
ter pipette equipped with a gamma-sterilised
tip (Gilson, Villiers-le-Bel, France) was
used to deposit one drop of inoculum
directly onto the surface of the tube con-
tents. Check tubes (replicates of the primary
standard tubes) were prepared as prescribed.
The tubes were then incubated at 37 °C
for up to 72 h. Two check tubes were
removed on a 24 h basis and titrated against
4 g·L−1 NaOH. After a maximum of 72 h,
or when the check tube with the highest
concentration of vitamin B12 primary stan-
dard required 8–12 mL NaOH, the tubes
were refrigerated at 4 °C to retard further
acid production. The relative growth in all
the standard and assay tubes was then deter-
mined by titrating against 4 g·L−1 NaOH to
a set end-point of pH 6.8, using a Methrohm
702 SM Titrino automatic titrator (Swiss
Lab Technologies, Standton, South Africa).
Averages of the replicate values were
used to plot the standard curves and these,
in turn, were employed to reference the
amount of vitamin B12 in the assay tubes.
The vitamin B12 content of the original sam-
ple was calculated taking all dilution factors
into account.
2.8. Data analyses
All statistical analyses of data were per-
formed using SPSS 16.0 for Windows®.
The relative standard deviation (RSD) was
calculated for the recovery data as a mea-
sure of inter-assay variability.
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3. RESULTS AND DISCUSSION
3.1. Linearity and sensitivity
The correlation coefﬁcient (R2) and the
regression coefﬁcient (R) were 0.9992 and
0.9996, respectively. Conﬁdence of linear-
ity, signiﬁed by R > 0.998, is closely related
to the rate of recovery, i.e. the accuracy of
the analysis [19]. The linear appearance of
the plot depicted in Figure 1, combined with
the fact that the correlation coefﬁcients
approached unity, indicated that the mea-
sured vitamin B12 concentration was linear
over the actual vitamin B12 concentration
range from 0.005 to 15 μg·mL−1 sample.
The HPLC method could, therefore, be
adjudged sufﬁciently sensitive to be used
as an analytical tool.
The limit of quantiﬁcation (LOQ), i.e.
the lowest vitamin B12 concentration where
reproducible results were obtained, was
0.005 μg·mL−1 sample. This compares
favourably to the LOQ of 0.01 μg·mL−1
sample reported by Heudi et al. [15].
However, since it excludes the lowest vita-
min B12 concentration reported for dairy
products, viz. 0.003 μg·mL−1 [11], the sen-
sitivity of the method was improved by




When a standard sample with expected
vitamin B12 concentration of 2.63 μg·mL
−1
was divided into 14 aliquots and analysed
repeatedly on different days, reproducible
resultswere obtained.Mean vitaminB12 con-
centration, 2.62 ± 0.02 μg·mL−1 (day 1) and
2.61 ± 0.02 μg·mL−1 (day 2), did not differ
signiﬁcantly (P = 0.73) and was close to
the expected value of 2.63 μg·mL−1. Good
repeatability (intermediate precision) was,
therefore, demonstrated.
The recovery of vitaminB12 from the sam-
ples and placebo (Tab. I) ranged from 98.6%
to 103.2% (average values), with the RSD
ranging from 2.68% to 6.79%. It was, there-
fore, reasonable to conclude that the extrac-
tion regime and the analytical procedure
effected complete dissolution of vitamin B12
in the matrices analysed in this study.
Statistical analysis of the results of the
microbiological assays vs. the HPLC analy-
ses of the same samples indicated that no
signiﬁcant difference existed (P > 0.05)
Vitamin B12 (μg.mL




































B12 concentration (Mean of n = 7)
Linear regression line
y = 0.103x + 0.108
R2 = 0.9992; R = 0.9996
Figure 1. Linearity of vitamin B12 analyses. Error bars indicate the SD.
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(Tab. II). The HPLC method is, therefore, a
valid alternative to themicrobiological assay.
3.3. Sample extraction
and HPLC assays
Sample chromatograms depict the results
for various samples (Fig. 2). The excellent
resolution of the B12 peak, together with
the absence of baseline noise, illustrated
the excellent selectivity of the HPLC
method. The results also reinforced the fact
that the extraction and analytical procedures
produced acceptable results when applied to
these food products and to synthetic media











































































tR  = 12.865
6 8 10 12 14 16 18 20
4 6 8 10 12 14 16 18 20
4 6 8 10 12 14 16 18 20 4 6 8 10 12 14 16 18 20
4 6 8 10 12 14 16 18 20
4 6 8 10 12 14 16 18 20
Figure 2. Sample chromatograms of the vitamin B12 standard (A, 0.005 μg·mL
−1) and (B,
15 μg·mL−1), vitamin B12 extracted from B12 medium fermented by strain J15 (C, 3.61 μg·mL
−1),
fortiﬁed skim milk (D, 1.28 μg·mL−1), fortiﬁed Amasi (E, 1.28 μg·mL−1) and fortiﬁed
Keﬁr (F, 1.31 μg·mL−1). Retention time (tR) next to the peak marks the B12 peak.













































tR  = 11.795
4 6 8 10 12 14 16 18 20
4 6 8 10 12 14 16 18 20 4 6 8 10 12 14 16 18 20
4 6 8 10 12 14 16 18 20
Figure 3. Chromatograms depicting sample puriﬁcation (A and C), followed by sample
concentration (B and D) using SPE techniques. Samples were extracted from B12 medium cultured
with strain J15 (A and B) and fortiﬁed Keﬁr (C and D). Vitamin B12 concentration was measured
(in μg·mL−1): 0.77 (A) and 0.34 (C) before and 3.77 (B) and 3.36 (D) after sample concentration.
Retention time (tR) marks each B12 peak.
Table I. Recovery results for HPLC determination of vitamin B12 in different samples, with
vitamin B12 added in various known concentrations.




Range Mean ± SDa
YEL with added vitamin B12 (n = 18) 0.1–12.5 94–107 98.6 ± 4.17 4.23
J10 in YEL broth with added vitamin B12
(n = 10)
0.1–12.5 95–107 100.77 ± 4.19 4.16
J19 in vitamin B12 broth with added
vitamin B12 (n = 10)
0.1–12.5 98–106 100.4 ± 2.95 2.94
Skim milk with added vitamin B12
(n = 12)
0.05–5.0 96–111 99.9 ± 6.79 6.79
Amasi with added vitamin B12 (n = 16) 0.05–5.0 98–115 103.2 ± 5.08 4.92
Keﬁr with added vitamin B12 (n = 10) 0.05–5.0 100–106 102.2 ± 2.74 2.68
a Mean ± SD.
b Relative standard deviation (%) = (SD/Mean) × 100.
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3.4. Sample puriﬁcation
and concentration
When comparing the vitamin B12 levels
before (Figs. 3A and 3C) and after
(Figs. 3B and 3D) sample concentration
using SPE, it is clear that this technique
resulted in a substantial increase in the
apparent concentration of vitamin B12 in a
broth sample cultured with strain J15 (from
0.77 to 3.77 in μg·mL−1, i.e. an almost ﬁve-
fold increase, Figs. 3A and 3B), as well as
in a fortiﬁed Keﬁr sample (from 0.34 to
3.36 μg·mL−1, i.e. an almost 10-fold
increase, Figs. 3C and 3D).
The signiﬁcance of this enhanced
response is that it increases the sensitivity of
the analysis. In other words, while the LOQ
was established at 0.005 μg·mL−1, with a
ﬁve-fold increase in sensitivity, as demon-
strated for the J15 sample, the LOQ will be
decreased to 0.001 μg·mL−1. Hence, using
SPE concentration makes this method suit-
able for the analysis of dairy products with
vitamin B12 levels as low as 0.003 μg·mL
−1.
Sample puriﬁcation resulted in cleaner
chromatograms. This is illustrated by the
absence of any peaks other than the
vitamin B12 peak (the KCN buffer and sol-
vent peaks are not shown since they elute
at tR < 6 min) (Figs. 3A–3D). Further-
more, the chromatograms depicted in
Figures 2C and 3A were both obtained
when analysing sample extracts of strain
J15 cultured in B12 medium. It is clear that
the compounds eluting immediately after
vitamin B12 (Fig. 2C) are absent after puri-
ﬁcation using SPE (Fig. 3A). Hence, this is
further conﬁrmation that effective puriﬁca-
tion was achieved.
4. CONCLUSIONS
The extraction protocol was shown to
effect complete recovery of vitamin B12
from the sample matrices. The HPLC
method was found to be selective, linear
(R > 0.998), accurate (recovery from
98.6% to 103.2%) and sensitive (LOQ =
0.005 μg·mL−1). It was also shown that
the sensitivity could be improved using
sample concentration. The method, there-
fore, is a rapid alternative to the more time
consuming microbiological assay.
Table II. Comparison of vitamin B12 results from HPLC and microbiological assays (n = 3).
Values are reported as mean ± SD.
Sample






J10 (YEL)a 0.25 ± 0.01 0.23 ± 0.01 0.40
J17 (YEL)a 0.22 ± 0.01 0.22 ± 0.01 0.82
J8 (B12 medium)
b 2.23 ± 0.19 2.25 ± 0.03 0.84
J9 (B12 medium)
b 0.29 ± 0.02 0.32 ± 0.04 0.31
J10 (B12 medium)
b 2.04 ± 0.07 2.12 ± 0.05 0.38
J15 (B12 medium)
b 1.69 ± 0.04 1.77 ± 0.01 0.06
J16 (B12 medium)
b 0.66 ± 0.01 0.77 ± 0.06 0.09
J17 (B12 medium)
b 0.25 ± 0.01 0.27 ± 0.01 0.29
J18 (B12 medium)
b 0.26 ± 0.01 0.33 ± 0.01 0.92
J19 (B12 medium)
b 0.14 ± 0.00 0.16 ± 0.02 0.20
a,b YEL and B12 media were sampled at 216 and 73 h, respectively.
c The Student’s t test (independent samples) was performed to establish whether the results of the two
methods differed signiﬁcantly. P ≤ 0.05 indicates signiﬁcance.
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